Skip to main content
Year archive

INVEX THERAPEUTICS LTD — 2020 filings

All 62 regulatory filings released by INVEX THERAPEUTICS LTD (IXC) in 2020, sourced directly from the official regulator.

62 Filings
2020 Period
2020 filings (62)
Filing Released Lang
Invex Successfully Concludes Protocol Assistance with EMA 3 pages 214.0KB
Regulatory Filings
2020-12-22 English
Ceasing to be a substantial holder 3 pages 1.4MB
Regulatory Filings
2020-12-01 English
Invex to Present at Bell Potter Healthcare Conference 2 pages 176.8KB
Regulatory Filings
2020-11-22 English
Appendix 3G 15 pages 262.6KB
Regulatory Filings
2020-11-18 English
Change of Director's Interest Notice 2 pages 244.8KB
Regulatory Filings
2020-11-18 English
Chairman's Address to Shareholders and Presentation 9 pages 455.8KB
Regulatory Filings
2020-11-17 English
Results of Meeting 3 pages 229.8KB
Regulatory Filings
2020-11-17 English
Investor Presentation 18 pages 1.1MB
Regulatory Filings
2020-11-04 English
Invex to Present at Upcoming Small Caps Virtual Conference 2 pages 180.0KB
Regulatory Filings
2020-11-03 English
Invex Provides Development Update 5 pages 244.6KB
Regulatory Filings
2020-10-29 English
Appendix 4C - quarterly 10 pages 411.2KB
Regulatory Filings
2020-10-22 English
Appendix 3G 16 pages 377.2KB
Regulatory Filings
2020-10-19 English
Amended Appendix 3G 16 pages 377.1KB
Regulatory Filings
2020-10-19 English
Amended Appendix 3G 15 pages 261.6KB
Regulatory Filings
2020-10-19 English
Notice of Annual General Meeting/Proxy Form 19 pages 954.7KB
Regulatory Filings
2020-10-11 English
Initial Director's Interest Notice 2 pages 238.3KB
Regulatory Filings
2020-10-04 English
Final Director's Interest Notice 2 pages 229.8KB
Regulatory Filings
2020-10-04 English
Director Appointment/Resignation 2 pages 182.2KB
Regulatory Filings
2020-09-30 English
AGM Date and Director Nominations 1 page 168.7KB
Regulatory Filings
2020-09-27 English
Appendix 4E and Annual Report 53 pages 1.3MB
Regulatory Filings
2020-08-27 English
Corporate Governance Statement 15 pages 304.1KB
Regulatory Filings
2020-08-27 English
Appendix 4G 14 pages 299.5KB
Regulatory Filings
2020-08-27 English
Quarterly Report and Appendix 4C with appendix 12 pages 465.8KB
Regulatory Filings
2020-08-06 English
Quarterly Report and Appendix 4C 11 pages 429.9KB
Regulatory Filings
2020-07-23 English
Conference Call Recording 1 page 171.0KB
Regulatory Filings
2020-07-23 English
Initial FDA and EMA Advice on Presendin Development 5 pages 221.3KB
Regulatory Filings
2020-07-22 English
Trading Halt 2 pages 362.9KB
Regulatory Filings
2020-07-21 English
Notice of Allowance for Key US Exenatide Patent 2 pages 178.3KB
Regulatory Filings
2020-07-20 English
Appendix 2A 22 pages 544.1KB
Regulatory Filings
2020-07-02 English
Change of Director's Interest Notice 3 pages 313.9KB
Regulatory Filings
2020-07-02 English
Ceasing to be a substantial holder 2 pages 116.4KB
Regulatory Filings
2020-07-02 English
Results of Meeting 1 page 45.9KB
Regulatory Filings
2020-06-29 English
Constitution 72 pages 553.0KB
Regulatory Filings
2020-06-29 English
Presentation of Exenatide Phase II Data at Headache Congress 2 pages 221.4KB
Regulatory Filings
2020-06-28 English
Change of Director's Interest Notice 3 pages 317.8KB
Regulatory Filings
2020-06-01 English
Ceasing to be a substantial holder 2 pages 1.1MB
Regulatory Filings
2020-06-01 English
Change in substantial holding 3 pages 310.7KB
Regulatory Filings
2020-06-01 English
Issue of Tranche 1 Placement Shares and Appendix 2A 22 pages 582.1KB
Regulatory Filings
2020-05-27 English
Change in substantial holding 2 pages 249.3KB
Regulatory Filings
2020-05-27 English
Change in substantial holding 2 pages 1.2MB
Regulatory Filings
2020-05-27 English
Ceasing to be a substantial holder 1 page 570.2KB
Regulatory Filings
2020-05-27 English
Change in substantial holding 2 pages 229.9KB
Regulatory Filings
2020-05-27 English
Notice of General Meeting/Proxy Form 17 pages 1.0MB
Regulatory Filings
2020-05-27 English
Postcard to Shareholders - General Meeting 5 pages 879.9KB
Regulatory Filings
2020-05-27 English
Succesful $26 million Share Placement 4 pages 251.7KB
Regulatory Filings
2020-05-21 English
Phase II Clinical Results and Capital Raising Presentation 34 pages 934.7KB
Regulatory Filings
2020-05-21 English
Proposed issue of Securities - IXC 5 pages 28.5KB
Regulatory Filings
2020-05-21 English
Proposed issue of Securities - IXC 5 pages 28.3KB
Regulatory Filings
2020-05-21 English
Exenatide Meets Key Endpoints in IIH Clinical Trial 8 pages 566.2KB
Regulatory Filings
2020-05-19 English
Trading Halt 2 pages 385.2KB
Regulatory Filings
2020-05-17 English
Virtual Health Conference Presentation 18 pages 389.1KB
Regulatory Filings
2020-04-30 English
Virtual Heath Conference 2 pages 181.9KB
Regulatory Filings
2020-04-28 English
Phase II Clinical Trial Update 4 pages 236.0KB
Regulatory Filings
2020-04-22 English
Appendix 3G - Issue of Options 13 pages 370.9KB
Regulatory Filings
2020-04-13 English
Quarterly Report and Appendix 4C 9 pages 363.3KB
Regulatory Filings
2020-04-01 English
Appendix 2A 22 pages 462.0KB
Regulatory Filings
2020-03-29 English
Investor Presentation 23 pages 531.5KB
Regulatory Filings
2020-03-08 English
Appendix 4D and Half-year Report 21 pages 419.3KB
Regulatory Filings
2020-02-26 English
Appendix 3B 17 pages 505.4KB
Regulatory Filings
2020-01-27 English
Appendix 3B 14 pages 551.1KB
Regulatory Filings
2020-01-20 English
Appendix 4C - quarterly 10 pages 304.5KB
Regulatory Filings
2020-01-16 English
Completion of Exenatide Phase II Clinical Trial 2 pages 178.5KB
Regulatory Filings
2020-01-12 English